Related references
Note: Only part of the references are listed.Differential Expression of Dicer, miRNAs, and Inflammatory Markers in Diabetic Ins2+/- Akita Hearts
Vishalakshi Chavali et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2014)
Regulation of SERCA pumps expression in diabetes
Angel Zarain-Herzberg et al.
CELL CALCIUM (2014)
Mechanisms of Altered Ca2+ Handling in Heart Failure
Min Luo et al.
CIRCULATION RESEARCH (2013)
Plasma active matrix metalloproteinase 9 and indices of diastolic function in patients with preserved systolic function
John W. Chu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Matrix metalloproteinase (MMP)-9: A proximal biomarker for cardiac remodeling and a distal biomarker for inflammation
Ganesh V. Halade et al.
PHARMACOLOGY & THERAPEUTICS (2013)
The interaction of Ca2+ with sarcomeric proteins: role in function and dysfunction of the heart
Hendrick E. D. J. ter Keurs
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases
A. Rietz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Ablation of MMP9 induces survival and differentiation of cardiac stem cells into cardiomyocytes in the heart of diabetics: a role of extracellular matrix
Paras Kumar Mishra et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2012)
Matrix metalloproteinase-9 deletion attenuates myocardial fibrosis and diastolic dysfunction in ageing mice
Ying Ann Chiao et al.
CARDIOVASCULAR RESEARCH (2012)
Targeted Sarcoplasmic Reticulum Ca2+ ATPase 2a Gene Delivery to Restore Electrical Stability in the Failing Heart
Michael J. Cutler et al.
CIRCULATION (2012)
Circulating Matrix Metalloproteinase-3 and Metalloproteinase-9 and Tissue Doppler Measures of Diastolic Dysfunction to Risk Stratify Patients With Systolic Heart Failure
Simona Buralli et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Matrix metalloproteinases cleave the β2-adrenergic receptor in spontaneously hypertensive rats
Stephen F. Rodrigues et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Attenuation of beta2-adrenergic receptors and homocysteine metabolic enzymes cause diabetic cardiomyopathy
Paras Kumar Mishra et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol
Paras K. Mishra et al.
CARDIOVASCULAR DIABETOLOGY (2010)
MMP-9 Gene Ablation and TIMP-4 Mitigate PAR-1-Mediated Cardiomyocyte Dysfunction: A Plausible Role of Dicer and miRNA
Paras Kumar Mishra et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2010)
Pharmacological targeting of beta-adrenergic receptor functions abrogates NF-kappa B signaling and MMP-9 secretion in medulloblastoma cells
Borhane Annabi et al.
ONCOTARGETS AND THERAPY (2010)
Gene Remodeling in Type 2 Diabetic Cardiomyopathy and Its Phenotypic Rescue with SERCA2a
Ioannis Karakikes et al.
PLOS ONE (2009)
Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia
Karni S. Moshal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Diabetic cardiomyopathy revisited
Sihem Boudina et al.
CIRCULATION (2007)
Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction
ML Lindsey et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and-2 in type 2 diabetes
MH Tayebjee et al.
DIABETES CARE (2004)
Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9
AM Romanic et al.
CARDIOVASCULAR RESEARCH (2002)
Share Paper
